In October 2024, Clover announced Phase I results in 70 older adults (60-85 years) who were RSV vaccine-naïve, and results indicated a potential best-in-class combined immunogenicity & tolerability ...

SCB Wealth serves three market segments: SCB Private, SCB First and SCB Prime. SCB Wealth offers a comprehensive suite of investment products and services, including deposits, lending, investments ...